Humeral Eccentric Reverse Metaphysis
K-Number: K210207 · 2021-03-26
ApplicantMedacta International S.A.
Decision Date2021-03-26
Product CodePHX
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
Humeral Eccentric Reverse Metaphysis is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2021-03-26 under approval number K210207. The device is classified under product code PHX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Humeral Eccentric Reverse Metaphysis?
Humeral Eccentric Reverse Metaphysis is a medical device that received FDA 510(k) clearance on 2021-03-26. It is manufactured by Medacta International S.A.. The 510(k) number is K210207.
When was Humeral Eccentric Reverse Metaphysis approved by the FDA?
Humeral Eccentric Reverse Metaphysis received FDA 510(k) clearance on 2021-03-26, under approval number K210207.
What company makes Humeral Eccentric Reverse Metaphysis?
Humeral Eccentric Reverse Metaphysis is manufactured by Medacta International S.A..
What is the FDA product code for Humeral Eccentric Reverse Metaphysis?
The FDA product code for Humeral Eccentric Reverse Metaphysis is PHX.
Other Devices by Medacta International S.A.
Related Devices (Code: PHX)
K161742Aequalis PerFORM Reversed, Aequalis PerFORM+ Reversed GlenoidTornier, Inc.
K161189Integra TITAN Reverse Shoulder SystemIntegra LifeSciences Corporation
K152754COMPREHENSIVE VAULT RECONSTRUCTION SYSTEM (VRS)Biomet Manufacturing Corp
K152966Aequalis Fx2Tornier S.A.S.
K173073AltiVate Anatomic to Reverse Conversion ModuleEncore Medical L.P.
K170414Arthrex Univers Revers Apex Humeral StemsArthrex, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.